Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Bujarski Robert JosephOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Premium)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:405Price:--
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Bujarski Robert JosephOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Converted)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,351Price:--
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Borkar Ratan SOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Premium)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:599Price:--
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Borkar Ratan SOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Converted)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,918Price:--
- Dec 01, 2020 (filed on Dec 03, 2020)Insider Name:Hodges Michelle A.Ownership Type:Direct OwnershipSecurities:Non-Qualified Stock OptionsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,105Price:--
- Dec 01, 2020 (filed on Dec 03, 2020)Insider Name:Hodges Michelle A.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:952Price:--
- Dec 01, 2020 (filed on Dec 03, 2020)Insider Name:Polan Mary Lake Ph DOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-11,000Price:$192.25
- Nov 18, 2020 (filed on Nov 20, 2020)Insider Name:Steward Randall JOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,034Price:--
- Nov 18, 2020 (filed on Nov 20, 2020)Insider Name:Steward Randall JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-513Price:$187.28
- Nov 18, 2020 (filed on Nov 20, 2020)Insider Name:Steward Randall JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,034Price:--
Filings by filing date
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Bujarski Robert JosephOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Premium)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:405Price:--
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Bujarski Robert JosephOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Converted)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,351Price:--
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Borkar Ratan SOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Premium)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:599Price:--
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Borkar Ratan SOwnership Type:Direct OwnershipSecurities:Restricted Stock Units (Converted)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,918Price:--
- Dec 01, 2020 (filed on Dec 03, 2020)Insider Name:Hodges Michelle A.Ownership Type:Direct OwnershipSecurities:Non-Qualified Stock OptionsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,105Price:--
- Dec 01, 2020 (filed on Dec 03, 2020)Insider Name:Hodges Michelle A.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:952Price:--
- Dec 01, 2020 (filed on Dec 03, 2020)Insider Name:Polan Mary Lake Ph DOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-11,000Price:$192.25
- Nov 18, 2020 (filed on Nov 20, 2020)Insider Name:Steward Randall JOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,034Price:--
- Nov 18, 2020 (filed on Nov 20, 2020)Insider Name:Steward Randall JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-513Price:$187.28
- Nov 18, 2020 (filed on Nov 20, 2020)Insider Name:Steward Randall JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,034Price:--
News
Biz Brief
Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 9975 Summers Ridge Road SAN DIEGO CA 92121 |
Tel: | 1-858-6468023 |
Website: | www.quidel.com |
IR: | See website |
Key People | ||
Kenneth F. Buechler Independent Chairman of the Board | Douglas C. Bryant President, Chief Executive Officer, Director | Randall J. Steward Chief Financial Officer |
Robert Joseph Bujarski Chief Operating Officer | Michael Donald Abney Senior Vice President - Distribution | Ratan S. Borkar Senior Vice President - International Commercial Operations |
Karen C. Gibson Senior Vice President, Information Systems and Business Transformation | Werner E. Kroll Senior Vice President - R&D | Edward Keith Russell Senior Vice President - Business Development |
Business Overview |
Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and medical conditions, including infectious diseases, cardiovascular diseases and conditions, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Amplivue, Lyra and Thyretain. |
Financial Overview |
For the nine months ended 30 September 2020, QuidelCorporation revenues increased from $382.7M to $852.5M. Netincome increased from $42.3M to $340.2M. Revenues reflectRapid Immunoassay segment increase from $126.8M to $417.6M,Molecular Diagnostic Solutions segment increase from $14.6Mto $118.2M. Net income benefited from Interest and otherexpense, net decrease of 62% to $4.6M (expense). |
Employees: | 1,250 as of Dec 31, 2019 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $8,477M as of Sep 30, 2020 |
Annual revenue (TTM): | $1,005M as of Sep 30, 2020 |
EBITDA (TTM): | $535.87M as of Sep 30, 2020 |
Net annual income (TTM): | $370.78M as of Sep 30, 2020 |
Free cash flow (TTM): | $193.73M as of Sep 30, 2020 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 42,067,646 as of Oct 23, 2020 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |